Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07271693 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Mar 1, 2027 → May 11, 2027
See other at-risk trials from Roche/Genentech

Record History

  1. Primary and study completion pushed from Mar 1, 2027 to May 11, 2027 Eligibility criteria expanded, about 17 words · Secondary endpoints: details revised at 1 of 10 entries Show 2 more changesShow less
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 1 of 10 entries
  2. Re-verified, no change to tracked fieldsv10
  3. Eligibility criteria expanded, about 37 wordsv9 See this version in full on ClinicalTrials.gov ↗
  4. Study Status, Contacts/Locations, Referencesv8
  5. 5 versions Re-verified since Jan 22, 2026, no change to tracked fieldsv3-v7
  6. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Jan 16, 2026 to Dec 22, 2025v2 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 16, 2026 to Dec 22, 2025
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Roche/Genentech
366 trials monitored
See 33 trials at risk
The main purpose of this study is to evaluate the safety and tolerability of single and multiple ascending doses of RO7806881 in healthy participants.
Trial Details
NCT Number NCT07271693
Lead Sponsor Hoffmann-La Roche
Conditions Healthy Volunteers
Enrollment 128 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov